Answers are grounded in this paper and cite their sources.
These results show the efficacy of an injectable ECM hydrogel alone as a potential therapy for treating patients with PAD. Our results indicate that the SKM hydrogel improved functional outcomes through stimulation of arteriogenesis and muscle progenitor cell recruitment.
No takes yet. Share an insight, caveat, or question.
Ungerleider et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: